[1] |
Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial [J]. Diabetes Care, 2011, 34(8): 1683-1688.
|
[2] |
晋柏,孙丽洲. 糖代谢异常子痫前期的防范 [J]. 中国实用妇科与产科杂志,2018, 34(5): 957-958.
|
[3] |
Inkster ME, Fahey TP, Donnan PT, et al. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies [J]. BMC Pregnancy Childbirth, 2006, 6: 30.
|
[4] |
Tennant PW, Glinianaia SV, Bilous RW, et al. Preexisting diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study [J]. Diabetologia, 2014, 57(2): 285-294.
|
[5] |
Galindo A, Burguillo AG, Azriel S, et al. Outcome of fetuses in women with pregestational diabetes mellitus [J]. J Perinat Med, 2006, 34(4): 323-331.
|
[6] |
American Diabetes Association. 13. Management of Diabetes in Pregnancy [J]. Diabetes Care, 2017, 40(Suppl 1): S114-S119.
|
[7] |
Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia inpregnancy [J]. Diabet Care, 2010, 33(3): 676-682.
|
[8] |
Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care [J]. Diabet Care, 2008, 31(5): 1060-1079.
|
[9] |
Hawthorne G. Maternal complications in diabetic pregnancy [J]. Best Pract Res Clin Obstet Gynaecol, 2011, 25(1): 77-90.
|
[10] |
Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes [J]. Diabet Care, 2007, 30(7):1920-1925.
|
[11] |
Morrison JL, Hodgson LA, Lim LL, et al. Diabetic retinopathy in pregnancy: a review [J]. Clin Exp Ophthalmol, 2016, 44(4): 321-334.
|
[12] |
Toda J, Kato S, Sanaka M, et al. The effect of pregnancy on the progression of diabetic retinopathy[J].Jpn J Ophthalmol,2016,60(6): 454-458.
|
[13] |
National Collaborating Centre for Women′s and Children′s Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period [M/OL]. London: National Institute for Health and Care Excellence (UK), 2015 [2020-12-6]. PMID: 25950069.
|
[14] |
de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial [J]. BMJ, 2010, 340: c2181.
|
[15] |
Australian Government Department of Health. MBS Reviews: Vitamin B12 testing Review Report [R/OL]. (2014-2) [2020-12-6].
URL
|
[16] |
Wald NJ, Law MR, Morris JK, et al. Quantifying the effect of folic acid[J]. Lancet, 2001, 358(9298): 2069-2073.
|
[17] |
The American College of Obstetricians and Gynecologists′ Committee. Practice bulletin No.187: neural tube defects [J]. Obstet Gynecol, 2017, 130(6): e279-e290.
|
[18] |
McGrogan A, Snowball J, Charlton RA. Statins during pregnancy: a cohort study using the General Practice Research Database to investigate pregnancy loss [J]. Pharmacoepidemiol Drug Saf, 2017, 26(7): 843-852.
|
[19] |
Lee MS, Hekimian A, Doctorian T, et al. Statin exposure during first trimester ofpregnancy is associated with fetal ventricular septal defect [J]. Int J Cardiol, 2018, 269: 111-113.
|
[20] |
Vestgaard M, Ringholm L, Laugesen CS, et al. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes [J]. Diabet Med, 2010, 27(4): 431-435.
|
[21] |
Rahman W, Rahman FZ, Yassin S, et al. Progression of retinopathy during pregnancy in type 1 diabetes mellitus [J]. Clin Exp Ophthalmol, 2007, 35(3): 231-236.
|
[22] |
Axer-Siegel R, Hod M, Fink-Cohen S, et al. Diabetic retinopathy during pregnancy [J]. Ophthalmology, 1996, 103(11): 1815-1819.
|
[23] |
Rasmussen KL, Laugesen CS, Ringholm L, et al. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes [J]. Diabetologia, 2010, 53(6): 1076-1083.
|
[24] |
Macones GA, Parry S, Nelson DB, et al. Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS)[J]. Am J Obstet Gynecol, 2010, 202(2): 147e1-147e8.
|
[25] |
Rudland VL, Price SAL, Hughes R, et al. ADIPS 2020 guideline for pre-existing diabetes and pregnancy[J]. Aust N Z J Obstet Gynaecol, 2020, 60(6): E18-E52.
|
[26] |
Murphy HR, Roland JM, Skinner TC, et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control [J]. Diabet Care, 2010, 33(12): 2514-2520.
|
[27] |
Mcelvy SS, Miodovnik M, Rosenn B,et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates togeneral population levels [J]. J Maternal-Fetal Neonatal Medi, 2000,9(1): 14-20.
|
[28] |
Murphy HR, Roland JM, Skinner TC,et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes:benefits beyond glycemic control [J]. Diabetes Care, 2010, 33(12): 2514-2520.
|